About DENTSPLY SIRONA (NASDAQ:XRAY)
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.
Industry, Sector and Symbol
Industry MED PRODS
Sub-IndustryHealth Care Supplies
Trailing P/E Ratio21.41
Forward P/E Ratio20.48
Sales & Book Value
Annual Sales$3.99 billion
Price / Sales3.21
Cash Flow$9.85 per share
Price / Cash5.72
Book Value$28.92 per share
Price / Book1.95
Return on Equity8.35%
Return on Assets5.61%
DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions
What is DENTSPLY SIRONA's stock symbol?
DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."
How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?
DENTSPLY SIRONA declared a quarterly dividend on Wednesday, February 14th. Investors of record on Thursday, March 29th will be given a dividend of $0.0875 per share on Friday, April 13th. This represents a $0.35 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Wednesday, March 28th. View DENTSPLY SIRONA's Dividend History.
How were DENTSPLY SIRONA's earnings last quarter?
DENTSPLY SIRONA Inc (NASDAQ:XRAY) announced its quarterly earnings results on Thursday, March, 1st. The medical instruments supplier reported $0.82 EPS for the quarter, topping the Zacks' consensus estimate of $0.81 by $0.01. The medical instruments supplier had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.06 billion. DENTSPLY SIRONA had a positive return on equity of 8.35% and a negative net margin of 39.39%. DENTSPLY SIRONA's quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.67 earnings per share. View DENTSPLY SIRONA's Earnings History.
When will DENTSPLY SIRONA make its next earnings announcement?
Where is DENTSPLY SIRONA's stock going? Where will DENTSPLY SIRONA's stock price be in 2018?
13 analysts have issued 1 year price objectives for DENTSPLY SIRONA's stock. Their forecasts range from $55.00 to $81.00. On average, they expect DENTSPLY SIRONA's share price to reach $67.75 in the next twelve months. View Analyst Ratings for DENTSPLY SIRONA.
What are Wall Street analysts saying about DENTSPLY SIRONA stock?
Here are some recent quotes from research analysts about DENTSPLY SIRONA stock:
- 1. Barrington Research analysts commented, "We are maintaining our OUTPERFORM investment rating, but are slightly reducing our price target to $70 from $73 in light of our reduced profitability estimates. We arrive at our price target by attaching an 18x multiple to our 2018 adjusted EBITDA estimate. We assume $1.1 billion in net debt 12 months from now." (3/5/2018)
- 2. According to Zacks Investment Research, "Over the last year, DENTSPLY SIRONA traded below the broader industry in terms of prices. The company's higher capital expenditure on product development and tough competition are expected to put margins under pressure. Unfavorable foreign exchange rate and integration risks are the major headwinds in the near term. However robust performance by the company’s flagship dental implants, CAD/CAM systems, imaging systems, treatment centers and orthodontic product platforms hold considerable promise over the long haul. Emerging markets like Asia-Pacific & the Middle East offer healthy growth opportunities on a long-term basis, as they remain vastly untapped with low dental products penetration. The company’s agreements with MedTech bigwigs Patterson Companies in Canada are likely to drive sales. DENTSPLY SIRONA has recently witnessed a rebound in sales in Asia, particularly Japan, and strong growth in Russia. Over the last year, DENTSPLY" (1/8/2018)
Who are some of DENTSPLY SIRONA's key competitors?
Some companies that are related to DENTSPLY SIRONA include Zimmer Biomet (ZBH), Cardinal Health (CAH), Align Technology (ALGN), AmerisourceBergen (ABC), Sunny Optical Tech (SNPTF), Lonza Group (LZAGY), IDEXX Laboratories (IDXX), Laboratory Corp. of America (LH), Coloplast A/S (CLPBY), Smith & Nephew (SNN), ResMed (RMD), Olympus (OCPNY), ABIOMED (ABMD), Teleflex (TFX), Perrigo (PRGO), Cooper Companies (COO), Varian Medical Systems (VAR) and Hologic (HOLX).
Who are DENTSPLY SIRONA's key executives?
DENTSPLY SIRONA's management team includes the folowing people:
- Donald M. Casey Jr., Chief Executive Officer, Director (Age 58)
- Nicholas W. Alexos CPA, Chief Financial Officer, Executive Vice President, Chief Administrative Officer (Age 53)
- Maureen J. MacInnis, Chief Human Resource Officer, Senior Vice President (Age 56)
- Keith J. Ebling, Executive Vice President, General Counsel, Secretary (Age 47)
- Rainer Berthan, Executive Vice President, Manufacturing and Supply Chain (Age 53)
- Eric K. Brandt, Non-Executive Independent Chairman of the Board (Age 55)
- Thomas Jetter Ph.D., Lead Independent Director (Age 60)
- David K. Beecken M.D., Director (Age 70)
- Betsy D. Holden, Director (Age 61)
- Arthur D. Kowaloff, Director (Age 70)
Who owns DENTSPLY SIRONA stock?
DENTSPLY SIRONA's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.17%), Generation Investment Management LLP (3.92%), Clearbridge Investments LLC (3.03%), Jackson Square Partners LLC (3.00%), Viking Global Investors LP (2.35%) and Atlanta Capital Management Co. L L C (2.07%). Company insiders that own DENTSPLY SIRONA stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Eric Brandt, Francis J Lunger, Harry M Jansen Kraemer Jr, James G Mosch, Mark Thierer, Maureen J Macinnis, Michael C Alfano, Nicholas W Alexos, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for DENTSPLY SIRONA.
Who sold DENTSPLY SIRONA stock? Who is selling DENTSPLY SIRONA stock?
DENTSPLY SIRONA's stock was sold by a variety of institutional investors in the last quarter, including Chilton Investment Co. LLC, Atlanta Capital Management Co. L L C, Millennium Management LLC, Deutsche Bank AG, Wells Fargo & Company MN, Westwood Holdings Group Inc., Independent Franchise Partners LLP and King Luther Capital Management Corp. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Christopher T Clark, Eric Brandt, Francis J Lunger and James G Mosch. View Insider Buying and Selling for DENTSPLY SIRONA.
Who bought DENTSPLY SIRONA stock? Who is buying DENTSPLY SIRONA stock?
DENTSPLY SIRONA's stock was acquired by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Viking Global Investors LP, Frontier Capital Management Co. LLC, Victory Capital Management Inc., Bank of New York Mellon Corp, Jackson Square Partners LLC, Adi Capital Management LLC and Macquarie Group Ltd.. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA.
How do I buy DENTSPLY SIRONA stock?
Shares of DENTSPLY SIRONA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DENTSPLY SIRONA's stock price today?
One share of DENTSPLY SIRONA stock can currently be purchased for approximately $56.33.
How big of a company is DENTSPLY SIRONA?
DENTSPLY SIRONA has a market capitalization of $12.95 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,573,000,000.00 in net income (profit) each year or ($6.88) on an earnings per share basis. DENTSPLY SIRONA employs 15,700 workers across the globe.
How can I contact DENTSPLY SIRONA?
DENTSPLY SIRONA's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]
MarketBeat Community Rating for DENTSPLY SIRONA (XRAY)MarketBeat's community ratings are surveys of what our community members think about DENTSPLY SIRONA and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
DENTSPLY SIRONA (NASDAQ:XRAY) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.62||2.58||2.67||2.60|
|Ratings Breakdown: ||1 Sell Rating(s)|
3 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
2 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$67.75||$69.82||$70.00||$65.78|
|Price Target Upside: ||20.27% upside||11.44% upside||7.71% upside||23.60% upside|
DENTSPLY SIRONA (NASDAQ:XRAY) Consensus Price Target History
DENTSPLY SIRONA (NASDAQ:XRAY) Analyst Ratings History
(Data available from 3/17/2016 forward)
DENTSPLY SIRONA (NASDAQ:XRAY) Earnings History and Estimates Chart
DENTSPLY SIRONA (NASDAQ XRAY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/1/2018||Q4 2017||$0.81||$0.82||$1.06 billion||$1.09 billion||View||Listen|
|11/3/2017||Q3 2017||$0.66||$0.70||$978.99 million||$1.01 billion||View||N/A|
|8/9/2017||Q2 2017||$0.65||$0.65||$1.00 billion||$992.70 million||View||Listen|
|5/9/2017||Q1 17||$0.50||$0.49||$916.55 million||$900.50 million||View||Listen|
|2/17/2017||Q4 2016||$0.65||$0.67||$1.02 billion||$996.50 million||View||Listen|
|11/4/2016||Q316||$0.63||$0.66||$967.68 million||$954.20 million||View||Listen|
|8/5/2016||Q216||$0.70||$0.76||$1.03 billion||$1.02 billion||View||Listen|
|5/6/2016||Q1||$0.63||$0.69||$741.80 million||$772.60 million||View||N/A|
|2/12/2016||Q415||$0.65||$0.65||$687.35 million||$671.10 million||View||Listen|
|10/28/2015||Q3||$0.63||$0.66||$667.00 million||$648.90 million||View||Listen|
|7/30/2015||Q215||$0.68||$0.73||$715.49 million||$698.00 million||View||Listen|
|5/6/2015||Q115||$0.57||$0.59||$690.16 million||$656.30 million||View||Listen|
|2/18/2015||Q414||$0.61||$0.60||$751.04 million||$719.00 million||View||Listen|
|10/29/2014||Q314||$0.60||$0.62||$725.83 million||$708.00 million||View||Listen|
|7/31/2014||Q2||$0.68||$0.69||$782.86 million||$765.20 million||View||Listen|
|5/6/2014||Q1||$0.56||$0.59||$747.27 million||$730.10 million||View||Listen|
|2/18/2014||Q4||$0.61||$0.61||$767.89 million||$753.70 million||View||Listen|
|10/29/2013||Q313||$0.56||$0.57||$716.13 million||$704.00 million||View||Listen|
|8/1/2013||Q2 2013||$0.65||$0.66||$782.73 million||$761.00 million||View||Listen|
|5/9/2013||Q1 2013||$0.56||$0.52||$732.87 million||$732.10 million||View||Listen|
|2/20/2013||Q4 2012||$0.56||$0.56||$748.56 million||$753.30 million||View||Listen|
DENTSPLY SIRONA (NASDAQ:XRAY) Earnings Estimates
2018 EPS Consensus Estimate: $2.76
2019 EPS Consensus Estimate: $2.98
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
DENTSPLY SIRONA (NASDAQ:XRAY) Dividend Information
|Payout Ratio:||-5.09% (Trailing 12 Months of Earnings) |
12.73% (Based on This Year's Estimates)
11.40% (Based on Next Year's Estimates)
DENTSPLY SIRONA (NASDAQ:XRAY) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
DENTSPLY SIRONA (NASDAQ XRAY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.99%
Institutional Ownership Percentage: 96.80%
DENTSPLY SIRONA (NASDAQ XRAY) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/8/2018||Eric Brandt||Director||Sell||6,409||$68.04||$436,068.36||12,073|| |
|11/13/2017||Francis J Lunger||Director||Sell||8,900||$65.90||$586,510.00|| |
|11/13/2017||Mark Thierer||Insider||Buy||77,000||$66.04||$5,085,080.00|| |
|11/13/2017||Nicholas W Alexos||CFO||Buy||50,000||$65.85||$3,292,500.00|| |
|4/24/2017||James G Mosch||CEO||Sell||50,600||$63.49||$3,212,594.00||105,083|| |
|4/7/2017||Christopher T Clark||CEO||Sell||89,700||$62.67||$5,621,499.00||112,067|| |
|3/9/2017||Ulrich Michel||Insider||Sell||24,000||$62.84||$1,508,160.00||94,067|| |
|3/2/2017||Eric Brandt||Director||Sell||2,941||$64.35||$189,253.35||4,722|| |
|3/1/2017||Bret W Wise||Insider||Sell||146,900||$64.17||$9,426,573.00||142,121|| |
|2/17/2017||Arthur D Kowaloff||Director||Sell||27,213||$62.00||$1,687,206.00||55,692|| |
|2/17/2017||Christopher T Clark||CEO||Sell||64,500||$60.70||$3,915,150.00||55,916|| |
|11/17/2016||James G Mosch||CEO||Sell||30,400||$60.93||$1,852,272.00||75,283|| |
|9/6/2016||Rainer Berthan||VP||Sell||5,000||$61.12||$305,600.00||34,370|| |
|8/25/2016||Maureen J Macinnis||SVP||Sell||45,100||$60.55||$2,730,805.00||36,730|| |
|8/23/2016||Maureen J Macinnis||SVP||Sell||17,650||$60.61||$1,069,766.50||19,630|| |
|6/2/2016||Rainer Berthan||VP||Sell||6,464||$62.56||$404,387.84||39,341|| |
|5/26/2016||Michael C Alfano||Director||Sell||3,000||$61.58||$184,740.00||8,758|| |
|5/16/2016||Harry M Jansen Kraemer Jr||Director||Sell||27,213||$62.17||$1,691,832.21||58,262|| |
|3/29/2016||Arthur D Kowaloff||Director||Sell||13,006||$62.00||$806,372.00||42,785|| |
|11/18/2015||Deborah Rasin||VP||Sell||4,500||$60.56||$272,520.00||4,429|| |
|11/4/2015||Michael C Alfano||Director||Sell||2,500||$62.15||$155,375.00||8,737|| |
|11/3/2015||Deborah Rasin||VP||Sell||14,000||$61.70||$863,800.00||8,929|| |
|3/30/2015||Christopher T Clark||Insider||Sell||85,566||$51.18||$4,379,267.88|| |
|2/20/2015||Deborah Rasin||VP||Sell||11,000||$52.47||$577,170.00|| |
|2/20/2015||Michael J Coleman||Director||Sell||18,000||$52.47||$944,460.00|| |
|1/9/2015||Robert J Size||VP||Sell||9,200||$52.97||$487,324.00|| |
|12/8/2014||Leslie A Jones||Director||Sell||18,000||$55.45||$998,100.00|| |
|12/4/2014||Albert Sterkenburg||VP||Sell||23,200||$55.62||$1,290,384.00|| |
|11/7/2014||Michael C Alfano||Director||Sell||20,000||$51.23||$1,024,600.00|| |
|11/5/2014||James G Mosch||VP||Sell||55,042||$51.25||$2,820,902.50|| |
|11/4/2014||Francis J Lunger||Director||Sell||9,160||$50.90||$466,244.00|| |
|10/31/2014||Albert Sterkenburg||VP||Sell||2,000||$50.51||$101,020.00|| |
|10/31/2014||John C Miles II||Director||Sell||20,000||$50.65||$1,013,000.00|| |
|8/25/2014||Leslie A Jones||Director||Sell||2,000||$48.30||$96,600.00|| |
|7/3/2014||Christopher T Clark||Insider||Sell||27,521||$47.74||$1,313,852.54|| |
|5/30/2014||Michael C Alfano||Director||Sell||2,764||$47.25||$130,599.00|| |
|5/19/2014||Leslie Jones||Director||Sell||2,000||$46.49||$92,980.00||95,892|| |
|5/12/2014||Robert Size||VP||Sell||5,049||$46.29||$233,718.21||11,588|| |
|12/11/2013||Bret Wise||Chairman||Sell||90,000||$48.50||$4,365,000.00||21,724|| |
|12/9/2013||Francis Lunger||Director||Sell||18,000||$47.66||$857,880.00||4,322|| |
|12/6/2013||Bret Wise||Chairman||Sell||24,323||$47.66||$1,159,234.18||30,294|| |
|12/2/2013||Bret Wise||Chairman||Sell||66,761||$47.53||$3,173,150.33||30,294|| |
|12/2/2013||William Hecht||Director||Sell||18,000||$47.49||$854,820.00||18,000|| |
|11/8/2013||Leslie Jones||Director||Sell||2,000||$47.68||$95,360.00||97,892|| |
|10/21/2013||Robert J Size||VP||Sell||14,262||$46.00||$656,052.00|| |
|9/11/2013||Robert Size||VP||Sell||8,200||$45.00||$369,000.00||11,501|| |
|9/10/2013||James G Mosch||VP||Sell||41,836||$43.95||$1,838,692.20|| |
|7/31/2013||Christopher T Clark||Insider||Sell||20,918||$43.00||$899,474.00|| |
|7/31/2013||Eric Brandt||Director||Sell||18,000||$43.00||$774,000.00|| |
|7/9/2013||Christopher T Clark||Insider||Sell||20,918||$42.00||$878,556.00|| |
|6/3/2013||Leslie A Jones||Director||Sell||2,840||$41.76||$118,598.40|| |
|3/12/2013||Paula H Cholmondeley||Director||Sell||9,000||$42.70||$384,300.00|| |
|12/21/2012||Bret W Wise||Chairman||Sell||4,349||$40.50||$176,134.50|| |
DENTSPLY SIRONA (NASDAQ XRAY) News Headlines
DENTSPLY SIRONA (NASDAQ:XRAY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
DENTSPLY SIRONA (NASDAQ:XRAY) Income Statement, Balance Sheet and Cash Flow Statement
DENTSPLY SIRONA (NASDAQ XRAY) Stock Chart for Saturday, March, 17, 2018